company background image
BIO logo

Biotest XTRA:BIO Stock Report

Last Price

€41.40

Market Cap

€1.3b

7D

-0.5%

1Y

-2.8%

Updated

23 Dec, 2024

Data

Company Financials +

Biotest Aktiengesellschaft

XTRA:BIO Stock Report

Market Cap: €1.3b

My Notes

Capture your thoughts, links and company narrative

Biotest Aktiengesellschaft Competitors

Price History & Performance

Summary of share price highs, lows and changes for Biotest
Historical stock prices
Current Share Price€41.40
52 Week High€43.00
52 Week Low€40.40
Beta0.25
1 Month Change-0.48%
3 Month Change-0.48%
1 Year Change-2.82%
3 Year Change-3.04%
5 Year Change115.63%
Change since IPO833.83%

Recent News & Updates

Recent updates

Shareholder Returns

BIODE BiotechsDE Market
7D-0.5%-3.5%-2.0%
1Y-2.8%-14.7%6.9%

Return vs Industry: BIO exceeded the German Biotechs industry which returned -14.7% over the past year.

Return vs Market: BIO underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is BIO's price volatile compared to industry and market?
BIO volatility
BIO Average Weekly Movement1.0%
Biotechs Industry Average Movement6.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: BIO has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: BIO's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19462,464Peter Janssenwww.biotest.com

Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.

Biotest Aktiengesellschaft Fundamentals Summary

How do Biotest's earnings and revenue compare to its market cap?
BIO fundamental statistics
Market cap€1.33b
Earnings (TTM)€68.50m
Revenue (TTM)€707.00m

14.9x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIO income statement (TTM)
Revenue€707.00m
Cost of Revenue€459.30m
Gross Profit€247.70m
Other Expenses€179.20m
Earnings€68.50m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 28, 2025

Earnings per share (EPS)1.73
Gross Margin35.04%
Net Profit Margin9.69%
Debt/Equity Ratio116.4%

How did BIO perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

2%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:56
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biotest Aktiengesellschaft is covered by 11 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BraunCommerzbank AG
Martin PossienkeGSN North America
Torben TeichlerHauck Aufhäuser Investment Banking